• Return to Headlines

Atricure Inc Shares Up 63.0% Since SmarTrend's Buy Recommendation (ATRC)

By Amy Schwartz

SmarTrend identified an Uptrend for Atricure Inc (NASDAQ:ATRC) on February 22nd, 2018 at $17.77. In approximately 5 months, Atricure Inc has returned 63.02% as of today's recent price of $28.96.

In the past 52 weeks, shares of Atricure Inc have traded between a low of $14.88 and a high of $30.96 and are now at $28.96, which is 95% above that low price. The 200-day and 50-day moving averages have moved 0.66% higher and 2.21% higher over the past week, respectively.

AtriCure, Inc. develops, manufactures, and sells surgical devices designed to create precise lesions in soft tissues. The Company's bipolar ablation system is used by cardiothoracic surgeons as a standard treatment alternative to create lesions in heart tissue to block the abnormal electrical impulses that cause atrial fibrillation.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Atricure Inc shares.

Log in and add Atricure Inc (ATRC) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights atricure inc

Ticker(s): ATRC